Skip to main content
Caplight Logo









Eywa Biotech

Eywa Biotech

Private
MontevideoHealthcare & Life Scienceshttps://www.eywa.bio/

Last Round

Seed

Oct 3, 2025

Total Funding Raised

$2.6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Eywa Biotech is a biotechnology company that develops clinical-grade psychedelic compounds for the treatment of mental health conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Mental Health, Clean Manufacturing

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

psychedelic compoundssynthetic biologybiomanufacturingactive pharmaceutical ingredientsAPIpsychedelic APIspsychedelic medicinepsilocybinsynbioprecision fermentationgenetic engineeringmental health treatmentAPI supplierbiosynthesismetabolic engineering5-MeO-DMTDMTstrain engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eywa Biotech Comparables

Compare Eywa Biotech with similar companies based on industry and business-model similarity.

Eywa Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CB Therapeutics
82%
Pharmala Biotech Holdings Inc.
74%
PsyBio Therapeutics Corp
70%

Eywa Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 3, 2025

Key People

Founding team and executive leadership

Victoria Costa Paz

Co-founder & CEO

Founding Team

Pablo Gonzalo Salaverria Izaguirre

Chief Operating Officer

Executive Team

Eywa Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 2, 2026

    Grew 27% QoQ, from 11 to 14 employees.

  • May 1, 2026

    Grew 44% QoQ from 9 to 13 employees.

Eywa Biotech Filings

Explore SEC and related filing metadata, where available.

Eywa Biotech filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eywa Biotech's valuation, stock price, and market status.

Is Eywa Biotech a public or private company?

Eywa Biotech is a private company.

What is the current stock price of Eywa Biotech?

Eywa Biotech is a private company with no public stock price. No recent secondary market data is available.

How much is Eywa Biotech worth (valuation)?

Valuation information for Eywa Biotech is not publicly available.

Can I buy Eywa Biotech stock?

Eywa Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Eywa Biotech's last funding round?

Eywa Biotech's most recent funding round was Seed on October 3, 2025.

Who are the main investors in Eywa Biotech?

Key investors in Eywa Biotech include Draper Associates.

Will Eywa Biotech IPO soon?

No public IPO plans have been announced for Eywa Biotech.

How can I track Eywa Biotech secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eywa Biotech's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMontevideo
Employee Range13
Year Founded2022
Last FundingOct 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?